Independent Research Finds Underlying Method for C2N’s p-Tau217 Ratio Blood Test Outperforms Other Tau Blood Tests Used for Alzheimer’s Diagnoses
ST. LOUIS–(BUSINESS WIRE)–#Alzheimers–A group of distinguished Alzheimer’s disease researchers has affirmed, in a new study published online in the journal Brain, the superiority of the methods that are the basis of C2N Diagnostics’ new p[hospho]-tau217 ratio test. Currently available as a unique research tool in Alzheimer’s clinical studies, C2N’s p-tau217 ratio test is nearing completion … [Read more…]
